Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
28M
-
Number of holders
-
39
-
Total 13F shares, excl. options
-
1.71M
-
Shares change
-
+405K
-
Total reported value, excl. options
-
$30.1M
-
Value change
-
+$8.04M
-
Put/Call ratio
-
0.92
-
Number of buys
-
23
-
Number of sells
-
-15
-
Price
-
$17.57
Significant Holders of Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB) as of Q2 2021
51 filings reported holding INMB - Inmune Bio, Inc. - Common Stock, par value $0.001 per share as of Q2 2021.
Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB) has 39 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.71M shares
of 28M outstanding shares and own 6.12% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (379K shares), BlackRock Inc. (184K shares), EAM Investors, LLC (162K shares), Ikarian Capital, LLC (147K shares), EAM Global Investors LLC (117K shares), DEUTSCHE BANK AG\ (106K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (75.7K shares), GEODE CAPITAL MANAGEMENT, LLC (73.8K shares), ROYAL BANK OF CANADA (66.4K shares), and Janney Montgomery Scott LLC (57.3K shares).
This table shows the top 39 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.